# Rima Nabbout

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/rima-nabbout/

## Facts

| Field | Value |
| --- | --- |
| Citations | 28,228 |
| Field | Epilepsy research and treatment |
| h-index | 77 |
| i10-index | 269 |
| Last Known Institution | Hôpital Necker-Enfants Malades |
| OpenAlex ID | https://openalex.org/A5008350546 |
| ORCID iD | 0000-0001-5877-4074 |
| Works | 663 |

## Researcher papers

Showing 12 of 19.

- [Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome](https://scholariq.org/papers/trial-of-cannabidiol-for-drug-resistant-seizures-in-the-dravet-syndrome/)
- [Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference](https://scholariq.org/papers/tuberous-sclerosis-complex-diagnostic-criteria-update-recommendations-of-the/)
- [International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: Position paper by the ILAE Task Force on Nosology and Definitions](https://scholariq.org/papers/international-league-against-epilepsy-classification-and-definition-of-epilepsy/)
- [ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions](https://scholariq.org/papers/ilae-classification-and-definition-of-epilepsy-syndromes-with-onset-in-neonates/)
- [Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference](https://scholariq.org/papers/tuberous-sclerosis-complex-surveillance-and-management-recommendations-of-the/)
- [Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study](https://scholariq.org/papers/adjunctive-everolimus-therapy-for-treatment-resistant-focal-onset-seizures/)
- [Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations](https://scholariq.org/papers/updated-international-tuberous-sclerosis-complex-diagnostic-criteria-and/)
- [Characterization of human disease phenotypes associated with mutations in <i>TREX1</i>, <i>RNASEH2A</i>, <i>RNASEH2B</i>, <i>RNASEH2C</i>, <i>SAMHD1</i>, <i>ADAR</i>, and <i>IFIH1</i>](https://scholariq.org/papers/characterization-of-human-disease-phenotypes-associated-with-mutations-in-i/)
- [Proposed consensus definitions for new‐onset refractory status epilepticus (NORSE), febrile infection‐related epilepsy syndrome (FIRES), and related conditions](https://scholariq.org/papers/proposed-consensus-definitions-for-new-onset-refractory-status-epilepticus-norse/)
- [De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy](https://scholariq.org/papers/de-novo-gain-of-function-kcnt1-channel-mutations-cause-malignant-migrating/)
- [ILAE definition of the Idiopathic Generalized Epilepsy Syndromes: Position statement by the ILAE Task Force on Nosology and Definitions](https://scholariq.org/papers/ilae-definition-of-the-idiopathic-generalized-epilepsy-syndromes-position/)
- [International League Against Epilepsy classification and definition of epilepsy syndromes with onset at a variable age: position statement by the ILAE Task Force on Nosology and Definitions](https://scholariq.org/papers/international-league-against-epilepsy-classification-and-definition-of-epilepsy-2/)

## Researcher topics

- [Epilepsy research and treatment](https://scholariq.org/topics/epilepsy-research-and-treatment/)
- [Pharmacological Effects and Toxicity Studies](https://scholariq.org/topics/pharmacological-effects-and-toxicity-studies/)
- [Tuberous Sclerosis Complex Research](https://scholariq.org/topics/tuberous-sclerosis-complex-research/)
- [Genetics and Neurodevelopmental Disorders](https://scholariq.org/topics/genetics-and-neurodevelopmental-disorders/)
- [Genomics and Rare Diseases](https://scholariq.org/topics/genomics-and-rare-diseases/)

## Researcher university

- [Hôpital Necker-Enfants Malades](https://scholariq.org/institutions/hopital-necker-enfants-malades/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
